Correction: Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy (Molecular Cancer, (2024), 23, 1, (147), 10.1186/s12943-024-02061-4)

  • Andriani Angelopoulou
  • , Giorgos Theocharous
  • , Dimitrios Valakos
  • , Aikaterini Polyzou
  • , Sophia Magkouta
  • , Vassilios Myrianthopoulos
  • , Sophia Havaki
  • , Marco Fiorillo
  • , Ioanna Tremi
  • , Konstantinos Vachlas
  • , Theodoros Nisotakis
  • , Dimitris Thanos
  • , Anastasia Pantazaki
  • , Dimitris Kletsas
  • , Jiri Bartek
  • , Russell Petty
  • , Dimitris Thanos
  • , Rory J. McCrimmon
  • , Angelos Papaspyropoulos (Lead / Corresponding author)
  • , Vassilis G. Gorgoulis (Lead / Corresponding author)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction: Mol Cancer 23, 147 (2024) Following publication of the original correspondence [1], the authors wish to extend their acknowledgements to provide a more clear and precise credit to Dr P Haramis, Dr L Mans and Dr G Gargiulo’s work that was included in their manuscript. First, they would like to thank Dr P Haramis and Dr L Mans for the work done in zebrafish and cite the data published in Dr Mans’ doctoral thesis [2] used in Figs. 1 C-F, S1B-E and S2 of the manuscript. They also thank Dr Haramis for her original concept of exploiting the hypermetabolic phenotype of lkb1 mutant zebrafish in a synthetic lethality screen. Finally, they would like to extend their acknowledgements to Dr G Gargiulo for the analysis of the RNA-seq experiments on zebrafish performed at the Genomics Core Facility of the NKI.

Original languageEnglish
Article number11
JournalMolecular Cancer
Volume25
Issue number1
Early online date12 Jan 2026
DOIs
Publication statusPublished - 12 Jan 2026

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy (Molecular Cancer, (2024), 23, 1, (147), 10.1186/s12943-024-02061-4)'. Together they form a unique fingerprint.

Cite this